Lei Zheng, MD, PhD
Departments of Oncology, Surgery; The Sidney Kimmel Cancer Center; The Skip Viragh Center for Pancreatic Cancer Research and Clinical Care; The Sol Goldman Pancreatic Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland
Lei Zheng, M.D., Ph.D. is an associate professor of Oncology and Surgery in the Gastrointestinal Oncology Program at the Johns Hopkins University School of Medicine and plays a leading role in the translational programs that focuses on the clinical development of novel vaccine- and antibody-based therapies for gastrointestinal cancers at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins. His clinical work is focused on multidisciplinary management for resectable and borderline resectable pancreatic cancer. In addition, he is a lead researcher in the group of Johns Hopkins Cancer Center’s physician scientists who have developed the pancreatic cancer GVAX vaccine. He has also applied his knowledge gained from pancreatic cancer immune-based therapies to the development of a colorectal cancer GVAX vaccine and is one of the lead investigators on this development. He is affiliated with the Tumor Immunology Program as a laboratory investigator. His primary laboratory research focus is on the identification of new targets for pancreatic cancer therapies by dissecting tumor microenvironment of pancreatic cancer.